Abstract
The objective of this prospective observational study was to assess the clinical significance of neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR) and lymphocyte–monocyte ratio (LMR) as potential biomarkers to identify post-PNL SIRS or sepsis. Demographic data and laboratory data including hemoglobin (Hb), total leucocyte count (TLC), serum creatinine, urine microscopy and culture were collected. The NLR, LMR and PLR were calculated by the mathematical division of their absolute values derived from routine complete blood counts from peripheral blood samples. Stone factors were assessed by non-contrast computerized tomography of kidneys, ureter and bladder (NCCT KUB) and included stone burden (Volume = L × W × D × π × 0.167), location and Hounsfield value and laterality. Intraoperative factors assessed were puncture site, tract size, tract number, operative time, the need for blood transfusion and stone clearance. Of 517 patients evaluated, 56 (10.8%) developed SIRS and 8 (1.5%) developed sepsis. Patients developing SIRS had significantly higher TLC (10.4 ± 3.5 vs 8.6 ± 2.6, OR 1.19, 95% CI 1.09–1.3, p = 0.000002), higher NLR (3.6 ± 2.4 vs 2.5 ± 1.04, OR 1.3, 95% CI = 1.09–1.5, p = 0.0000001), higher PLR (129.3 ± 53.8 vs 115.4 ± 68.9, OR 1.005, 95% CI 1.001–1.008, p = 0.005) and lower LMR (2.5 ± 1.7 vs 3.2 ± 1.8, OR 1.18, 95% CI 1.04–1.34, p = 0.006). Staghorn stones (12.8 vs 3.24%, OR 4.361, 95% CI 1.605–11.846, p = 0.008) and long operative times (59.6 ± 14.01 vs 55.2 ± 16.02, OR 1.01, 95% CI 1.00–1.03, p = 0.05) had significant association with postoperative SIRS. In conclusion, NLR, PLR and LMR can be useful independent, easily accessible and cost-effective predictors for early identification of post-PNL SIRS/sepsis.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Percutaneous nephrolithotomy (PNL) is the surgical option of choice for upper urinary tract calculi of size > 2 cm and selected calculi < 2 cm [1]. Clinical spectrum of infective complications post-PNL range from transient fever to sever sepsis, with urosepsis reported in 0.9 to 4.7% of PCNL procedures [2,3,4]. Sepsis is also considered one of the most common causes of perioperative mortality after PNL [2, 5]. Female gender, diabetes, pyuria, large stone, staghorn stone, infected stone, positive pelvic urine culture and use of nephrostomy tube [6,7,8,9,10,11] are important predictors of postoperative SIRS. This study is aimed to assess the clinical significance of neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR) and lymphocyte–monocyte ratio (LMR) as potential biomarkers to identify post-PNL SIRS or sepsis.
Patients and methods
After institutional ethics committee approval and registration with Clinical Trial registry of India (REF/2018/09/021711), we did a prospective observational study of consecutive patients undergoing PNL at the urology department of a tertiary referral center from Karnataka, India, between November 2018 and October 2019. Standard protocols were followed for evaluation, treatment and follow-up. Demographic data collected were age, body mass index (BMI), comorbidities including hypertension, diabetes mellitus and history of previous PNL. Laboratory data included hemoglobin (Hb), total leucocyte count (TLC), serum creatinine, urine microscopy and culture. The NLR, LMR and PLR were calculated by the mathematical division of their absolute values derived from routine complete blood counts from peripheral blood samples on the day prior to surgery. Stone factors were assessed by non-contrast computerized tomography of kidneys, ureter and bladder (NCCT KUB) and included stone burden (Volume = L × W × D × π × 0.167), location and Hounsfield value and laterality. Intraoperative factors assessed were puncture site, tract size, tract number, operative time, the need for blood transfusion, stone clearance, usage of ureteral stent or nephrostomy tube and any ancillary procedures. The operative procedure followed a standardized prone PNL protocol, under general anesthesia and IV third-generation cephalosporin at induction. A sterile preoperative urine culture was ensured in all patients. Postoperative blood parameters included Hb, TLC, and serum creatinine as per the clinical condition. Analgesia was provided using parenteral tramadol. Postoperative complications were documented using the modified Clavien–Dindo grading system [12]. Patients with up to Grade 1 complications were discharged on postoperative day 2. Postoperative fever was defined as temperature > 38 °C. Systemic inflammatory response syndrome (SIRS) was defined as the presence of two of more of the following parameters: body temperature > 38 °C or < 36 °C, heart rate > 90/min, respiratory rate > 20 breaths/min and white blood cell count > 12 × 109 or < 4 × 109 cells/L. Sepsis was defined as both SIRS and a positive postoperative blood or urine culture [13].
Statistical analysis was done on SPSS, version 16.0. Categorical variables were expressed in frequencies with percentages and compared using Chi-square or Fisher’s exact test, continuous variables as mean and standard deviation and compared using Student’s t test for those with normal distribution and median with interquartile range with comparison using Mann–Whitney test for those with skewed distribution and a p value ≤ 0.05 considered significant. Univariate analysis was done to check the relation between the dependent variable (occurrence of SIRS/sepsis) and each of the independent variables. Multivariate analysis was then performed using logistic regression to establish the predictive factors for the development of AKI. A receiver operating characteristic (ROC) curve was constructed, and area under curve was used to derive a cutoff value for the variable.
Results
Of 517 patients evaluated, mean age was 48.1 ± 13.9 years, 56 (10.8%) developed post-PNL SIRS and 8 (1.5%) developed sepsis. The details of patient demography and stone characteristics with the univariate analysis for predictive factors for development of postoperative SIRS and sepsis are mentioned in Tables 1 and 2.
Patients developing SIRS had significantly lower preoperative hemoglobin (12.8 ± 2.3 vs 13.4 ± 1.8, OR 0.86, 95% CI 0.7–0.9, p = 0.04), higher TLC (10.4 ± 3.5 vs 8.6 ± 2.6, OR 1.19, 95% CI 1.09–1.3, p = 0.000002), higher NLR (3.6 ± 2.4 vs 2.5 ± 1.04, OR 1.3, 95% CI 1.09–1.5, p = 0.0000001), higher PLR (129.3 ± 53.8 vs 115.4 ± 68.9, OR 1.005, 95% CI 1.001–1.008, p = 0.005) and lower LMR (2.5 ± 1.7 vs 3.2 ± 1.8, OR 1.18, 95% CI 1.04–1.34, p = 0.006). Staghorn stones (12.8 vs 3.24%, OR 4.361, 95% CI 1.605–11.846, p = 0.008) and long operative times (59.6 ± 14.0 vs 55.2 ± 16.0, OR 1.01, 95% CI 1.00–1.03, p = 0.05) had significant association with postoperative SIRS. Length of hospital stay (days) was significantly more in the SIRS cohort (3.3 ± 1.7 vs 2.2 ± 1.7, OR 1.31, 95% CI 1.15–1.49, p = 0.00003). On multivariable logistic regression analysis, the independent risk factors for SIRS were history of previous ipsilateral PNL (OR 1.0, 95% CI = 0.36–1.56, p = 0.01), raised preoperative TLC (OR 1.22, 95% CI 1.04–1.42, p = 0.01), raised NLR (OR = 1.6, 95% CI = 1.22–2.24, p = 0.001), raised PLR (OR = 1.008, 95% CI = 1.002–1.014, p = 0.008) and low LMR (OR 1.3, 95% CI 1.03–1.56, p = 0.02).
Predictive values for sepsis post-PNL were high BMI (27.3 ± 1.9 vs 25.1 ± 2.9, p = 0.03), diabetes mellitus (50 vs 17.7%, p = 0.04), low LMR (2.6 ± 1.7 vs 4.1 ± 2.8, p = 0.02) and high stone density (993 ± 253 vs 753 ± 407, p = 0.009). All patients with sepsis were managed with intravenous antibiotics as per culture sensitivity and no patients required intensive care support in our cohort. Sepsis significantly increased the length of hospital stay (days) (3.3 ± 1.7 vs 2.3 ± 1.8, OR 1.31, 95% CI 1.15–1.49, p = 0.001).
On ROC analysis, the cutoff for preoperative NLR to predict postoperative SIRS was 2.03 with 82% sensitivity and 31% specificity with the area under the curve of 0.596 (p = 0.018) (Fig. 1). Cutoff for postoperative sepsis was 2.45 with 87% sensitivity and 31% specificity with area under the curve of 0.639 (p = 0.17) (Fig. 1). The threshold for PLR for postoperative SIRS was 110.62 with 80.2% sensitivity and 50.5% specificity with area under curve of 0.663 (p = 0.00006). Threshold for postoperative sepsis was 120.25 with 87.5% sensitivity and 53.2% specificity with area under the curve of 0.627 (p = 0.21). The cutoff value for LMR for postoperative SIRS was 3.23 with 83.9% sensitivity and 42% specificity with area under the curve of 0.649 (p = 0.0002). Cutoff value for postoperative sepsis was 2.88 with 87.5% sensitivity and 55% specificity with area under the curve of 0.726 (p = 0.02) (Fig. 2).
In this cohort, 21/517 (4.1%) patients had staghorn calculi. Among them 7 patients (33.3%) developed SIRS and 14 patients (66.7%) did not develop SIRS. Out of the 496 (95.6%) non-staghorn patients, 49 (9.8%) developed SIRS and 447 (90.1%) did not develop SIRS (OR 4.56, 95% CI 1.75–11.84, p = 0.0018). In the staghorn cohort, sensitivity and specificity of high NLR (> 2.0), high PLR (> 110.6) and low LMR (< 3.2) to predict SIRS were 85.7% and 78.6%, 83.3% and 71.4% and 71.4% and 71.4%, respectively, whereas sensitivity and specificity of low hemoglobin (Hb < 120gm/L) were 57.1% and 71.4%.
Discussion
Infection-related complications post-PNL range from transient fever to SIRS and sepsis. Incidence of fever post-PNL ranges from 10 to 25% [14, 15]. Incidence of SIRS in our cohort (10.83%) was much less than the reported incidence of 16.7—27.4% [2, 7, 10, 16,17,18]. This could be attributed to ensuring a preoperative sterile urine culture in all patients. In the largest prospective CROES study [19] evaluating the post-PNL complications, 10.5% patients developed fever, UTI in 0.6% and 0.2% progressing to sepsis.
Postoperative sepsis in the absence of bacteremia or bacteriuria could be hypothesized to persisting bacterial endotoxins in infected stones [11, 20, 21]. ‘Nanobacteria’ have also been theorized in stone formation and post-PNL infective complications [11, 22, 23]. Lack of a uniform consensus on the preoperative risk factors makes it imperative to identify a biomarker that is inexpensive and readily available. While TLC is a less sensitive marker, NLR, PLR and LMR can be useful in identifying systemic inflammation. These have been utilized in predicting prognosis in malignancies [24,25,26,27], inflammatory disorders [28], atherosclerosis [29], cardiovascular disorders [30] or metabolic syndrome [31, 32]. The role of these mediators in stone crystallization has established the immune response, oxidative stress and inflammatory cell response theory of stone formation, especially in patients with metabolic syndrome [33,34,35].
In our prospective evaluation preoperative NLR, PLR and LMR are significantly associated with post-PNL SIRS. This is in concordance with the sparse literature [15, 18, 34] on the predictive value of these biomarkers in stone disease. The presence of stone causes release of inflammatory mediators suchas IL-6, IL-7, IL-8, TNF-α and GCSF, causing increased neutrophil counts. These accumulated cytokines in the tissue microenvironment provides an adequate environment for further stone formation [34]. Exaggerated inflammatory response suppresses the immune response by decreasing the cytolytic activity of lymphocytes, T cells and natural killer cells [34, 36]. Platelets are rich in proinflammatory agents and are capable of releasing active inflammatory metabolites [37]. Monocytes are also key regulators in systemic inflammatory response [38] Therefore, an increased preoperative NLR and PLR and decreased LMR can be indicative of an ongoing inflammatory reaction. These markers derived from complete blood count have become part of routine evaluation and are inexpensive. Higher NLR, PLR and lower LMR can be used as indicator for predicting SIRS and urosepsis, especially with negative urine cultures. Active anti-infective treatment during the perioperative period is vital to prevent SIRS and its progression to urosepsis.
Females have been known to have a higher incidence of infective complications post-PNL [39,40,41] as also seen in this study, although not being statistically significant. Low hemoglobin was significantly associated with postoperative SIRS which is in concordance with the available literature [39]. Diabetes mellitus has been independently related to post-PNL SIRS [41] as also seen in this study. Commonly reported risk factors for postoperative SIRS such as stone size, number of tracts, blood transfusion [7, 15, 16] which increase the complexity of the procedure and increased irrigation time were not found to be significantly associated in this patient cohort. Stag horn stones harbour colonized bacteria making preoperative urine sterilisation difficult therefore are commonly associated with postoperative sepsis [42] as seen in this study. Hard stones increase the operative time and both these factors were significantly associated with postoperative SIRS in this study as also reported in literature [43].
Other biomarkers such as C-reactive protein (CRP), erythrocyte sediment rate (ESR) procalcitonin and CRP/albumin ratio [39, 44, 45] have been reported as useful predictors of postoperative infection. But added costs do not allow them to be incorporated in the routine preoperative evaluation. NLR can be easily derived from peripheral blood cell count and not only forms a useful infective marker, but also related to sepsis severity [46]. Hemoglobin (anemia) is another such easily available cost-effective predictor of SIRS [18, 39], but the sensitivity and specificity of NLR, PLR and LMR in predicting postoperative SIRS have been proven to be much better than those of low hemoglobin. Different cutoff values have been suggested in multiple reports studying bacteremia, ICU stay or postoperative mortality [15, 34, 39, 47, 48]. This lack of consensus for a common value has limited the application of these hematologic markers in clinical practice and therefore requires more comprehensive prospective multi-institutional studies for improved evidence and standardization.
Conclusion
Pathogenesis of postoperative infection is multifactorial and NLR, PLR and LMR can be useful independent, easily accessible and cost-effective predictors for post-PNL SIRS/sepsis. Patients with NLR > 2.03, PLR > 110.62 and LMR < 3.23 should be carefully followed for early identification of postoperative infective complications. More prospective studies are required to compare the accuracy of these biomarkers with the other risk factors to strengthen its clinical validation.
References
Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T (2016) EAU guidelines on interventional treatment for urolithiasis. Eur Urol 69(3):475–482. https://doi.org/10.1016/j.eururo.2015.07.041
De La Rosette J, Denstedt J, Geavlete P, Keeley F, Matsuda T, Pearle M, CROES URS study group (2014) The clinical research office of the endourological society ureteroscopy global study: indications, complications, and outcomes in 11,885 patients. J Endourol 28(2):131–139. https://doi.org/10.1089/end.2013.0436
Michel MS, Trojan L, Rassweiler JJ (2007) Complications in percutaneous nephrolithotomy. Eur Urol 51(4):899–906. https://doi.org/10.1016/j.eururo.2006.10.020
Bansal SS, Pawar PW, Sawant AS, Tamhankar AS, Patil SR, Kasat GV (2017) Predictive factors for fever and sepsis following percutaneous nephrolithotomy: a review of 580 patients. Urol Ann 9(3):230. https://doi.org/10.4103/UA.UA_166_16
Fuller A, Razvi H, Denstedt JD, Nott L, Hendrikx A, Luke M, de la Rosette J (2014) The clinical research office of the endourological society percutaneous nephrolithotomy global study: outcomes in the morbidly obese patient—a case control analysis. Canad Urol Assoc J 8(5–6):E393. https://doi.org/10.5489/cuaj.2258
Omar M, Noble M, Sivalingam S, El Mahdy A, Gamal A, Farag M, Monga M (2016) Systemic inflammatory response syndrome after percutaneous nephrolithotomy: a randomized single-blind clinical trial evaluating the impact of irrigation pressure. J Urol 196(1):109–114. https://doi.org/10.1016/j.juro.2016.01.104
Mariappan P, Smith G, Bariol SV, Moussa SA, Tolley DA (2005) Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol 173(5):1610–1614. https://doi.org/10.1097/01.ju.0000154350.78826.96
Dogan HS, Guliyev F, Cetinkaya YS, Sofikerim M, Ozden E, Sahin A (2007) Importance of microbiological evaluation in management of infectious complications following percutaneous nephrolithotomy. Int Urol Nephrol 39(3):737–742. https://doi.org/10.1007/s11255-006-9147-9
Jou YC, Lu CL, Chen FH, Shen CH et al (2015) Contributing factors for fever after tubeless percutaneous nephrolithotomy. Urology 85(3):527–530. https://doi.org/10.1016/j.urology.2014.10.032
Koras O, Bozkurt IH, Yonguc T et al (2015) Risk factors for postoperative infectious complications following percutaneous nephrolithotomy: a prospective clinical study. Urolithiasis 43(1):55–60. https://doi.org/10.1007/s00240-014-0730-8
Kreydin EI, Eisner BH (2013) Risk factors for sepsis after percutaneous renal stone surgery. Nat Rev Urol 10(10):598–605. https://doi.org/10.1038/nrurol.2013.183
De La Rosette JJ, Opondo D, Daels FP, Giusti G, Serrano A, Kandasami SV, Croes Pcnl Study Group (2012) Categorisation of complications and validation of the Clavien score for percutaneous nephrolithotomy. Eur Urol 62(2):246–255. https://doi.org/10.1016/j.eururo.2012.03.055
Levy MM, Fink MP, Marshall JC et al (2003) 2001 sccm/esicm/accp/ats/sis international sepsis definitions conference. Intensive Care Med 29(4):530–538. https://doi.org/10.1007/s00134-003-1662-x
Seitz C, Desai M, Häcker A, Hakenberg OW, Liatsikos E, Nagele U, Tolley D (2012) Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy. Eur Urol 61(1):146–158. https://doi.org/10.1016/j.eururo.2011.09.016
Sen V, Bozkurt IH, Aydogdu O, Yonguc T et al (2016) Significance of preoperative neutrophil–lymphocyte count ratio on predicting postoperative sepsis after percutaneous nephrolithotomy. Kaohsiung J Med Sci 32(10):507–513. https://doi.org/10.1016/j.kjms.2016.08.008
Chen L, Xu QQ, Li JX, Xiong LL, Wang XF, Huang XB (2008) Systemic inflammatory response syndrome after percutaneous nephrolithotomy: an assessment of risk factors. Int J Urol 15(12):1025–1028. https://doi.org/10.1111/j.1442-2042.2008.02170.x
Erdil T, Bostanci Y, Ozden E, Atac F, Yakupoglu YK, Yilmaz AF, Sarikaya S (2013) Risk factors for systemic inflammatory response syndrome following percutaneous nephrolithotomy. Urolithiasis 41(5):395–401. https://doi.org/10.1007/s00240-013-0570-y
Cetinkaya M, Buldu I, Kurt O, Inan R (2017) Platelet-to-lymphocyte ratio: a new factor for predicting systemic inflammatory response syndrome after percutaneous nephrolithotomy. Urol J 14(5):4089–4093
Desai M, De Lisa A, Turna B, Rioja J, On behalf of the CROES PCNL Study Group et al (2011) The clinical research office of the endourological society percutaneous nephrolithotomy global study: staghorn versus nonstaghorn stones. J Endourol 25(8):1263–1268. https://doi.org/10.1089/end.2011.0055
McALEER IM, Kaplan GW, Bradley JS, Carroll SF, Griffith DP (2003) Endotoxin content in renal calculi. J Urol 169(5):1813–1814. https://doi.org/10.1097/01.ju.0000061965.51478.79
Rao PN, Dube DA, Weightman NC, Oppenheim BA, Morris J (1991) Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol 146(4):955–960. https://doi.org/10.1016/S0022-5347(17)37974-0
Kajander EO, Çiftçioglu N (1998) Nanobacteria: an alternative mechanism for pathogenic intra-and extracellular calcification and stone formation. Proc Natl Acad Sci 95(14):8274–8279. https://doi.org/10.1073/pnas.95.14.8274
Çiftçioglu N, Björklund M, Kuorikoski K, Bergström K, Kajander EO (1999) Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 56(5):1893–1898. https://doi.org/10.1046/j.1523-1755.1999.00755.x
de Martino M, Pantuck AJ, Hofbauer S, Waldert M, Shariat SF, Belldegrun AS, Klatte T (2013) Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma. J Urol 190(6):1999–2004. https://doi.org/10.1016/j.juro.2013.06.082
Kantola T, Klintrup K, Väyrynen JP et al (2012) Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer 107(10):1729–1736. https://doi.org/10.1038/bjc.2012.456
Van Soest RJ, Templeton AJ, Vera-Badillo FE et al (2015) Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. Ann Oncol 26(4):743–749. https://doi.org/10.1093/annonc/mdu569
Ozyalvacli ME, Ozyalvacli G, Kocaaslan R, Cecen K, Uyeturk U, Kemahlı E, Gucuk A (2015) Neutrophil-lymphocyte ratio as a predictor of recurrence and progression in patients with high-grade pT1 bladder cancer. Can Urol Assoc J 9(3–4):E126. https://doi.org/10.5489/cuaj.2523
Bahadır A, Baltacı D, Türker Y et al (2015) Is the neutrophil-to-lymphocyte ratio indicative of inflammatory state in patients with obesity and metabolic syndrome? Anatol J Cardiol 15(10):816. https://doi.org/10.5152/akd.2014.5787
Balta S, Celik T, Mikhailidis DP, Ozturk C, Demirkol S, Aparci M, Iyisoy A (2016) The relation between atherosclerosis and the neutrophil–lymphocyte ratio. Clin Appl Thromb Hemost 22(5):405–411. https://doi.org/10.1177/1076029615569568
Verdoia M, Schaffer A, Barbieri L, Aimaretti G, Marino P, Sinigaglia F, Novara Atherosclerosis Study Group (2015) Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease. Diabetes Metab 41(4):304–311. https://doi.org/10.1016/j.diabet.2015.01.001
Yasar Z, Buyuksirin M, Ucsular FD et al (2015) Is an elevated neutrophil-to-lymphocyte ratio a predictor of metabolic syndrome in patients with chronic obstructive pulmonary disease. Eur Rev Med Pharmacol Sci 19(6):956–962
Buyukkaya E, Karakaş MF, Karakaş E et al (2014) Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost 20(2):159–163. https://doi.org/10.1177/1076029612459675
Mao W, Wu J, Zhang Z, Xu Z, Xu B, Chen M (2021) Neutrophil-lymphocyte ratio acts as a novel diagnostic biomarker for kidney stone prevalence and number of stones passed. Transl Androl Urol. https://doi.org/10.21037/tau-20-890
Tang K, Liu H, Jiang K, Ye T et al (2017) Predictive value of preoperative inflammatory response biomarkers for metabolic syndrome and post-PCNL systemic inflammatory response syndrome in patients with nephrolithiasis. Oncotarget 8(49):85612. https://doi.org/10.18632/oncotarget.20344
Fujii Y, Okada A, Yasui T, Niimi K et al (2013) Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis. PLoS ONE 8(4):e61343. https://doi.org/10.1371/journal.pone.0061343
Petrie HT, Klassen LW, Kay HD (1985) Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol 134(1):230–234
Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD (2019) The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med 39(4):345–357. https://doi.org/10.3343/alm.2019.39.4.345
Lee JS, Kim NY, Na SH, Youn YH, Shin CS (2018) Reference values of neutrophil-lymphocyte ratio, lymphocyte–monocyte ratio, platelet–lymphocyte ratio, and mean platelet volume in healthy adults in South Korea. Medicine. https://doi.org/10.1097/MD.0000000000011138
Xu H, Hu L, Wei X, Niu J, Gao Y, He J, Hou J (2019) The predictive value of preoperative high-sensitive C-reactive protein/albumin ratio in systemic inflammatory response syndrome after percutaneous nephrolithotomy. J Endourol 33(1):1–8. https://doi.org/10.1089/end.2018.0632
Aghdas FS, Akhavizadegan H, Aryanpoor A, Inanloo H, Karbakhsh M (2006) Fever after percutaneous nephrolithotomy: contributing factors. Surg Infect 7(4):367–371. https://doi.org/10.1089/sur.2006.7.367
Liu C, Zhang X, Liu Y, Wang P (2013) Prevention and treatment of septic shock following mini-percutaneous nephrolithotomy: a single-center retrospective study of 834 cases. World J Urol 31(6):1593–1597. https://doi.org/10.1007/s00345-012-1002-2
Rivera M, Viers B, Cockerill P, Agarwal D, Mehta R, Krambeck A (2016) Pre-and postoperative predictors of infection-related complications in patients undergoing percutaneous nephrolithotomy. J Endourol 30(9):982–986. https://doi.org/10.1089/end.2016.0191
Gonen M, Turan H, Ozturk B, Ozkardes H (2008) Factors affecting fever following percutaneous nephrolithotomy: a prospective clinical study. J Endourol 22(9):2135–2138. https://doi.org/10.1089/end.2008.0139
Ganesan V, Brown RD, Jimenez JA, De S, Monga M (2017) C-reactive protein and erythrocyte sedimentation rate predict systemic inflammatory response syndrome after percutaneous nephrolithotomy. J Endourol 31(7):638–644. https://doi.org/10.1089/end.2016.0884
Zheng J, Li Q, Fu W, Ren J et al (2015) Procalcitonin as an early diagnostic and monitoring tool in urosepsis following percutaneous nephrolithotomy. Urolithiasis 43(1):41–47. https://doi.org/10.1007/s00240-014-0716-6
Zahorec R (2001) Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102(1):5–14
Terradas R, Grau S, Blanch J, Riu M, Saballs P, Castells X, Horcajada JP, Knobel H (2012) Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study. PloS one 7(8):e42860. https://doi.org/10.1371/journal.pone.0042860
de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever PC (2010) Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care 14(5):1–8. https://doi.org/10.1186/cc9309
Funding
Open access funding provided by Manipal Academy of Higher Education, Manipal.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared that they have no conflict of interest.
Ethical approval
The study was conducted as an observational study after obtaining the institute ethical committee clearance (IEC 447/2018) and also CTRI approval (REF/2018/09/021711) in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kriplani, A., Pandit, S., Chawla, A. et al. Neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR) and lymphocyte–monocyte ratio (LMR) in predicting systemic inflammatory response syndrome (SIRS) and sepsis after percutaneous nephrolithotomy (PNL). Urolithiasis 50, 341–348 (2022). https://doi.org/10.1007/s00240-022-01319-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-022-01319-0